Objective To evaluate the diagnostic accuracy and efficacy on cervical precancerous lesions
and cervical cancer by HPV 16/18 E6 protein detection. Methods A total of 439 females with …

Objective: To investigate the triaging efficacy of the human papillomavirus (HPV) 16/18 E7
oncoprotein assay for high-grade cervical intraepithelial neoplasia (CIN2+) screening in …

Objective To evaluate the clinical value of human papillomavirus (HPV) E6 and E7
oncoprotein (HPV E6/E7) detection in the early screening of cervical cancer. Methods This …

This study examined the efficacy of the OncoE6™ Cervical Test, careHPV™ and visual
inspection with acetic acid (VIA) in identifying women at risk for cervical cancer and their …

Background Cervical cancer is the second-most common gynecological cancer, early
screening plays a key role in the diagnosis and treatment of cervical intraepithelial …

Background Colposcopy is recommended once human papillomavirus (HPV) 16/18
infection is detected. However, not all HPV16/18-positive women will necessarily develop …

Objective To analyze the differences of positive detection rate and copy number of human
papillomavirus (HPV) DNA and E6/E7 mRNA between different grades of cervical lesions …

Abstract Objective The Onco E6™ Cervical Test, based on detection of the E6 oncoprotein of
HPV 16 and 18 genotypes is evaluated as a screen for the early detection cervical neoplasia …

HPV‐16 and− 18 account for about 80% of cervical cancers. We evaluated the performance
of HPV‐16/18 oncoprotein to predict precancer and cancer in corresponding tissue biopsy …

Purpose A high-risk human papillomavirus E6/E7 mRNA (HR-HPV mRNA) assay is widely
used in cervical cancer screening in China. However, it is still unclear whether stand-alone …